Why aren’t patients being told truth about electric shock therapy? Leaflets on the treatment contain at least one inaccurate statement about safety and effectiveness, investigation shows By Lois Rogers For The Daily Mail Published: 00:33 BST, 15 June 2021 | Updated: 14:01 BST, 15 June 2021 Jacqui Quibbell has suffered from ‘crippling periods of depression… Read More »
Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease, according to a new study co-led by researchers at Johns Hopkins Bloomberg School of Public Health. The findings suggest that older males who have recovered from COVID-19… Read More »
The treatment being provided to United States President Donald Trump could pave the way to fighting COVID-19, says one of Australia’s top scientists. Professor Peter Doherty, who shared the Nobel Prize for Medicine in 1996 for his work on how the immune system recognises virus-infected cells, says a vaccine might not be the only answer.… Read More »
Gyroscope Therapeutics, a retinal gene therapy company, has developed the Orbit subretinal delivery system (SDS). The technology is designed to deliver therapies to the retina without the need for invasive procedures, such as vitrectomies, which involve removing the gel-like substance within the eye, or retinotomies, which involve making a hole in the retina. The company… Read More »
FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis Print this page Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically… Read More »